Limited Access Datasets are available for the following NIMH studies:
Study Descriptions
- Treatment of Major Depression with St. John's Wort (Hypericum)
- Multimodal Treatment Study of Children with Attention Deficit and Hyperactivity Disorder (MTA)
- Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): in Patients with Alzheimer’s Disease
- Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Schizophrenia*
- Sequenced Treatment Alternatives to Relieve Depression (STAR*D)*
- Treatment for Adolescents with Depression Study (TADS)*
- Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)*
- Treatment of SSRI-Resistant Depression In Adolescents (TORDIA)
- Research Units in Pediatric Psychopharmacology (RUPP) Studies: Treatment of Autism in Children and Adolescents
- Research Units in Pediatric Psychopharmacology (RUPP) Studies: Treatment For Anxiety in Children
- Research Units in Pediatric Psychopharmacology (RUPP) Studies: Methylphenidate in Children and Adolescents With Pervasive Development Disorders
- Treatment of Early Age Mania (TEAM)
Procedures for Requesting Limited Access Datasets
Investigators wishing to request any of the above datasets must obtain and submit a Data Use Certificate (DUC) in order for NIMH to release the dataset. Please note that the DUC requires the institution's Federal Wide Assurance (FWA) number and the signature of the institution's official.
To request a DUC, send an email to: nimhdatasets@mail.nih.gov. Be sure to specify the dataset that you are requesting.
*NOTE: Trials marked with an asterisk also collected genetics-related biomaterials from willing participants. The biomaterial, genetics data, and companion clinical data for those participants are available from the NIMH Center for Collaborative Genetic Studies and may be requested under the Center’s Distribution Agreement. These genetics data and companion clinical data are not available from the NIMH Clinical Trials Limited Access Datasets office.
